Stem Cell Based Therapy for Muscular Dystrophies: Cell Types and Environmental Factors Influencing Their Efficacy

Código QR

Stem Cell Based Therapy for Muscular Dystrophies: Cell Types and Environmental Factors Influencing Their Efficacy

None

Guardado en:

Detalles Bibliográficos
Autores principales:	Morgan, Jennifer, Alameddine, Hala
Formato:	Electrónico Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2012
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/36745
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Muscle Satellite Cells and Duchenne Muscular Dystrophy
por: Miyagoe-Suzuki, Yuko, et al.
Publicado: (2012)

Abnormal Ion Homeostasis and Cell Damage in Muscular Dystrophy
por: Iwata, Yuko, et al.
Publicado: (2012)

Myogenic Potential of Murine Embryonic Stem Cells in the Dmdmdx Mouse Model for Duchenne Muscular Dystrophy
por: Ayub-Guerrieri, Danielle, et al.
Publicado: (2011)

Diagnosis of the Muscular Dystrophies
por: Waddell, Leigh B., et al.
Publicado: (2012)

Hereditary muscular dystrophies
por: V. B. Doronin, et al.
Publicado: (2009-06-01)

Genetic Therapy for Duchenne Muscular Dystrophy: Principles and Progress
por: Koo, Taeyoung, et al.
Publicado: (2012)

Duchenne Muscular Dystrophy: Experimental models on Physical Therapy
por: Gaiad, Thais, et al.
Publicado: (2012)

Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
por: V. M. Suslov, et al.
Publicado: (2024-11-01)

Consensus concept of modern effective therapy for Duchenne muscular dystrophy
por: T. A. Gremyakova, et al.
Publicado: (2023-06-01)

Duchenne Muscular Dystrophy and Brain Function
por: Anderson, J.L., et al.
Publicado: (2012)

Rehabilitation in Muscular Dystrophies: Changing Approach
por: Groot, Imelda J.M. de, et al.
Publicado: (2012)

Advances in Molecular Analysis of Muscular Dystrophies
por: Ankala, Arunkanth, et al.
Publicado: (2012)

BREAKTHROUGH IN DUCHENNE MUSCULAR DYSTROPHY TREATMENT
por: article Editorial
Publicado: (2022-07-01)

Progress and Challenges in AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy
por: Takeda, Shin'Ichi, et al.
Publicado: (2011)

Database of Wards for Patients with Muscular Dystrophy in Japan
por: Saito, Toshio, et al.
Publicado: (2012)

Strength and Functional Measurement for Patients with Muscular Dystrophy
por: Lu, Yen-Mou, et al.
Publicado: (2012)

LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
por: E. V. Resnik, et al.
Publicado: (2024-10-01)

Congenital muscular dystrophies: classification and diagnostic strategy
por: François Rivier, et al.
Publicado: (2015-02-01)

New classification of limb-girdle muscular dystrophy
por: O. P. Sidorova, et al.
Publicado: (2022-09-01)

Muscular dystrophy associated with the DMD gene in women
por: E. O. Vorontsova, et al.
Publicado: (2024-09-01)

Is cardiac autonomic modulation influenced by beta blockers in adolescents with Duchenne Muscular Dystrophy?
por: Silva-Magalhães Talita Dias da, et al.
Publicado: (2025-07-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
por: article Editorial
Publicado: (2023-08-01)

Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review
por: Anna Teresa Michalska, et al.
Publicado: (2025-07-01)

MEROSIN-DEFICIENT CONGENITAL MUSCULAR DYSTROPHY (CMD1A): CLINICAL CASE OF CONGENITAL MUSCULAR DYSTROPHY INVOLVING CENTRAL NERVOUS SYSTEM
por: O. A. Klochkova, et al.
Publicado: (2014-07-01)

AON-Mediated Exon Skipping for Duchenne Muscular Dystrophy
por: Verhaart, Ingrid E. C., et al.
Publicado: (2012)

Altered Gene Expression Pathways in Duchenne Muscular Dystrophy
por: Juretić, Nevenka, et al.
Publicado: (2012)

Duchenne Muscular Dystrophy: Therapeutic Approaches to Restore Dystrophin
por: Spitali, Pietro, et al.
Publicado: (2012)

Duchenne Muscular Dystrophy: Modern Approaches in Patient Management
por: Inga V. Anisimova, et al.
Publicado: (2023-11-01)

Postural control in early stages of Duchenne muscular dystrophy
por: Cristhina Bonilha Huster Siegle, et al.
Publicado: (2025-06-01)

Computer task performance by subjects with Duchenne muscular dystrophy
por: Malheiros SR, et al.
Publicado: (2015-12-01)

Current and emerging treatment strategies for Duchenne muscular dystrophy
por: Mah J
Publicado: (2016-07-01)

The hereditary progressive muscular dystrophy type 2A (calpainopathy): a clinical case
por: D. A. Grishina, et al.
Publicado: (2015-05-01)

Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
por: S. B. Artemyeva, et al.
Publicado: (2024-01-01)

Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
por: E. V. Zinina, et al.
Publicado: (2024-09-01)

Psychosocial Support Needs of Families of Boys with Duchenne Muscular Dystrophy
por: Mah, Jean K., et al.
Publicado: (2012)

Nuclear Poly (A)-Binding Protein and Oculopharyngeal Muscular Dystrophy
por: Bag, Jnanankur, et al.
Publicado: (2012)

Clinical and genetic characteristics of congenital muscular dystrophies (part 2)
por: P. A. Chausova, et al.
Publicado: (2020-08-01)

Clinical and genetic characteristics of congenital muscular dystrophies (Part 1)
por: P. A. Chausova, et al.
Publicado: (2020-06-01)

Multi-Modal Analysis of Satellite Cells Reveals Early Impairments at Pre-Contractile Stages of Myogenesis in Duchenne Muscular Dystrophy
por: Sophie Franzmeier, et al.
Publicado: (2025-06-01)

Inherited progressive limb-girdle muscular dystrophy type 2A (calpainopathy): a review of literature
por: D. A. Grishina, et al.
Publicado: (2015-05-01)